HMGB1 and serum lipopolysaccharide activity: Recombinant HMGB1 has been found to induce acute inflammation in animal models of lung injury and endotoxemia [7,29], and anti-HMGB1 antibody attenuated endotoxin-induced lethality even when administration of antibody was delayed until after early cytokine response [7,31].